Is the product customizable?

No, this product is non-customized.

How should the product be stored?

Store in an airtight, closed container protected from light at a cool place.

What is the expiration date of the batch?

For batch D20240721, the expiration date is July 20, 2026.

Supply Peptide+Snac Lyophilized Powder (oral grade)

Name: Supply Peptide+Snac Lyophilized Powder (oral grade)
Brand: Wuhan Hanweishi Pharmchem Co., Ltd.
SKU: 1910126915

Hubei, ChinaWuhan Hanweishi Pharmchem Co., Ltd.

US$50.00-100.00

1 gram

Sample price:US$100.00/gram.Request sample

Product profile

Customization

Available

Powder

Yes

Customized

Non-Customized

Model NO.

Oral /Injection

Certification

GMP, HSE, ISO 9001, USP, BP

Suitable for

Elderly, Children, Adult

State

Solid

Purity

>99%

Transport Package

1/5/10/20/50g/Bag/Carton

Specification

32*28*45

Trademark

trademark as per request

Origin

China

HS Code

2942000000

Production Capacity

10 Kilogram/Month

Key features

High Purity Level: Purity exceeds 99% with assay results reaching 99.2%.

Multiple Certifications: Certified under GMP, HSE, ISO 9001, USP, and BP standards.

Broad Target Audience: Suitable for elderly, children, and adults.

Consistent Quality Control: Batch D20240721 meets all in-house standards with low impurities.

Global Market Reach: Exports to North America, Europe, Asia, Africa, and the Middle East.

Flexible Payment Terms: Accepts LC, T/T, D/P, Western Union, and Money Gram.

Fast Lead Time: Peak and off-peak season lead times are within 15 workdays.

Stable Storage Requirements: Requires airtight, closed containers stored in cool, dark places.

Company profile

High Repeat Buyers ChoiceYears of Export ExperienceExperienced TeamExhibition Experience

Wuhan Hanweishi Pharmchem Co., Ltd.

Hubei, China

Business Type: Manufacturer/Factory, Trading CompanyExport Year: 2013-07-12Nearest Port: QINGDAO, SHENZHEN, ShanghaiAverage Response Time: ≤11.82hTerms of Payment: LC, T/T, D/P, etc.International Commercial Terms(Incoterms): FOB, CFR, CIF, CIP, CPT

AI-Powered supplier vetting

SummaryWuhan Hanweishi Pharmchem Co., Ltd. is a China-based limited company described as both a trading company and manufacturer/factory, with nine employees and a broad pharmaceutical, chemical, supplement, and related product scope. It has inventory capability, export experience of 10 years, and reports that 90% of total sales are exports. The supplier accepts FOB, CIF, and CFR quotation terms and has participated in CPHI China 2023. Its service infrastructure is limited: it has no overseas warehouse, showroom, agent, or branch, and offers services in zero countries according to the provided data. R&D and innovation evidence is weak, with no new products launched in the past year, no SDK, no 3D software design service, and only minor customization, although ODM service is available. No certification information, customer cases, or sufficient financial assessment evidence is provided.

Supplier typeThe supplier is identified as a limited company and is described as both a trading company and manufacturer/factory, while another record classifies it as a trading company. Its stated scope includes import, export, and agency activities, indicating a trading-led business with manufacturing/factory capability also reported.

After-Sales capabilityThe supplier reports inventory capability and has participated in an offline trade show, but it has no overseas warehouse, showroom, agent, or branch, and the overseas service-country count is stated as zero. Service governance is also weak because no written service-assessment or corrective/preventive-action procedures or records were provided.

R&D capabilityInnovation evidence is limited: no new products were launched in the past year, there is no SDK, no 3D software design service, and the supplier is not identified as a professional technical supplier. ODM service is available, but the overall evidence does not demonstrate strong ongoing innovation.

Customization capabilityThe supplier offers minor customization and ODM services. These explicit services demonstrate some customization capability, but the stated level is limited and does not indicate extensive or advanced customization.